Abstract:Background. Breast invasive carcinoma (BRCA) is not a single disease as each subtype has a distinct morphology structure. Although several computational methods have been proposed to conduct breast cancer subtype identification, the specific interaction mechanisms of genes involved in the subtypes are still incomplete. To identify and explore the corresponding interaction mechanisms of genes for each subtype of breast cancer can impose an important impact on the personalized treatment for different patients. Methods. We integrate the biological importance of genes from the gene regulatory networks to the differential expression analysis and then obtain the weighted differentially expressed genes (weighted DEGs). A gene with a high weight means it regulates more target genes and thus holds more biological importance. Besides, we constructed gene coexpression networks for control and experiment groups, and the significantly differentially interacting structures encouraged us to design the corresponding Gene Ontology (GO) enrichment based on gene coexpression networks (GOEGCN). The GOEGCN considers the two-side distinction analysis between gene coexpression networks for control and experiment groups. The method allows us to study how the modulated coexpressed gene couples impact biological functions at a GO level. Results. We modeled the binary classification with weighted DEGs for each subtype. The binary classifier could make a good prediction for an unseen sample, and the experimental results validated the effectiveness of our proposed approaches. The novel enriched GO terms based on GOEGCN for control and experiment groups of each subtype explain the specific biological function changes according to the two-side distinction of coexpression network structures to some extent. Conclusion. The weighted DEGs contain biological importance derived from the gene regulatory network. Based on the weighted DEGs, five binary classifiers were learned and showed good performance concerning the “Sensitivity,” “Specificity,” “Accuracy,” “F1,” and “AUC” metrics. The GOEGCN with weighted DEGs for control and experiment groups presented a novel GO enrichment analysis results and the novel enriched GO terms would further unveil the changes of specific biological functions among all the BRCA subtypes to some extent. The R code in this research is available at https://github.com/yxchspring/GOEGCN_BRCA_Subtypes.

SRBCTs Subtype Recognition Based on Gene Expression Profiles

Informative Gene Selection for Cancer Subtype Classification with BP Neural Networks

Research on Models for SRBCT Prediction

Using feature selection and Bayesian network identify cancer subtypes based on proteomic data

Cancer Subtype Recognition and Feature Selection with Gene Expression Profiles

Neighborhood Rough Set Model Based Gene Selection for Multi-subtype Tumor Classification

Molecular Subtyping of Cancer Based on Distinguishing Co-Expression Modules and Machine Learning

Subtype Dependent Biomarker Identification and Tumor Classification from Gene Expression Profiles.

RNA-Seq-Based Breast Cancer Subtypes Classification Using Machine Learning Approaches

Breast Cancer Case Identification Based on Deep Learning and Bioinformatics Analysis

Cancer Molecular Classification Based on Support Vector Machines

A Self-Training Subspace Clustering Algorithm under Low-Rank Representation for Cancer Classification on Gene Expression Data

Study of tumor molecular diagnosis model based on artificial neural network with gene expression profile

Deep-Learning-Based Cancer Profiles Classification Using Gene Expression Data Profile

Comparative Study of Cancer Classification by Analysis of RNA-seq Gene Expression Levels

Identifying and Analyzing Different Cancer Subtypes Using RNA-seq Data of Blood Platelets.

An Integrated Approach for Identifying Molecular Subtypes in Human Colon Cancer Using Gene Expression Data

Multi-class Tumor Subtype Recognition Based on Neural Networks

Network Based Stratification of Major Cancers by Integrating Somatic Mutation and Gene Expression Data.

ANMM4CBR: a Case-Based Reasoning Method for Gene Expression Data Classification

Improvement of Cancer Subtype Prediction by Incorporating Transcriptome Expression Data and Heterogeneous Biological Networks.